 | • レポートコード：QYR2104Z4819 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、増殖性糖尿病性網膜症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗VEGF剤、コルチコステロイド）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・増殖性糖尿病性網膜症の市場動向 ・企業の競争状況、市場シェア ・増殖性糖尿病性網膜症の種類別市場規模（抗VEGF剤、コルチコステロイド） ・増殖性糖尿病性網膜症の用途別市場規模（病院、診療所、その他） ・増殖性糖尿病性網膜症の北米市場規模2016-2027（アメリカ、カナダ） ・増殖性糖尿病性網膜症のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・増殖性糖尿病性網膜症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・増殖性糖尿病性網膜症の中南米市場規模2016-2027（メキシコ、ブラジル） ・増殖性糖尿病性網膜症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Intas Pharmaceuticals、Santen Pharmaceutical、Bausch Health、Allergan Plc、Regeneron Pharmaceuticals、Merck KGaA、Cipla、Genentech, Inc. (Roche Holdings)、Novartis、Pfizer） ・結論 |
Market Analysis and Insights: Global Proliferative Diabetic Retinopathy Market
The global Proliferative Diabetic Retinopathy market size is projected to reach US$ 624.2 million by 2026, from US$ 430.5 million in 2019, at a CAGR of 5.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Proliferative Diabetic Retinopathy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Proliferative Diabetic Retinopathy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Proliferative Diabetic Retinopathy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Proliferative Diabetic Retinopathy market.
Global Proliferative Diabetic Retinopathy Scope and Market Size
Proliferative Diabetic Retinopathy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Proliferative Diabetic Retinopathy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Anti-VEGF Agents
Corticosteroids
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Intas Pharmaceuticals
Santen Pharmaceutical
Bausch Health
Allergan Plc
Regeneron Pharmaceuticals
Merck KGaA
Cipla
Genentech, Inc. (Roche Holdings)
Novartis
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Proliferative Diabetic Retinopathy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anti-VEGF Agents
1.2.3 Corticosteroids
1.3 Market by Application
1.3.1 Global Proliferative Diabetic Retinopathy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Proliferative Diabetic Retinopathy Market Perspective (2016-2027)
2.2 Proliferative Diabetic Retinopathy Growth Trends by Regions
2.2.1 Proliferative Diabetic Retinopathy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Proliferative Diabetic Retinopathy Historic Market Share by Regions (2016-2021)
2.2.3 Proliferative Diabetic Retinopathy Forecasted Market Size by Regions (2022-2027)
2.3 Proliferative Diabetic Retinopathy Industry Dynamic
2.3.1 Proliferative Diabetic Retinopathy Market Trends
2.3.2 Proliferative Diabetic Retinopathy Market Drivers
2.3.3 Proliferative Diabetic Retinopathy Market Challenges
2.3.4 Proliferative Diabetic Retinopathy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Proliferative Diabetic Retinopathy Players by Revenue
3.1.1 Global Top Proliferative Diabetic Retinopathy Players by Revenue (2016-2021)
3.1.2 Global Proliferative Diabetic Retinopathy Revenue Market Share by Players (2016-2021)
3.2 Global Proliferative Diabetic Retinopathy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Proliferative Diabetic Retinopathy Revenue
3.4 Global Proliferative Diabetic Retinopathy Market Concentration Ratio
3.4.1 Global Proliferative Diabetic Retinopathy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Proliferative Diabetic Retinopathy Revenue in 2020
3.5 Proliferative Diabetic Retinopathy Key Players Head office and Area Served
3.6 Key Players Proliferative Diabetic Retinopathy Product Solution and Service
3.7 Date of Enter into Proliferative Diabetic Retinopathy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Proliferative Diabetic Retinopathy Breakdown Data by Type
4.1 Global Proliferative Diabetic Retinopathy Historic Market Size by Type (2016-2021)
4.2 Global Proliferative Diabetic Retinopathy Forecasted Market Size by Type (2022-2027)
5 Proliferative Diabetic Retinopathy Breakdown Data by Application
5.1 Global Proliferative Diabetic Retinopathy Historic Market Size by Application (2016-2021)
5.2 Global Proliferative Diabetic Retinopathy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Proliferative Diabetic Retinopathy Market Size (2016-2027)
6.2 North America Proliferative Diabetic Retinopathy Market Size by Type
6.2.1 North America Proliferative Diabetic Retinopathy Market Size by Type (2016-2021)
6.2.2 North America Proliferative Diabetic Retinopathy Market Size by Type (2022-2027)
6.2.3 North America Proliferative Diabetic Retinopathy Market Size by Type (2016-2027)
6.3 North America Proliferative Diabetic Retinopathy Market Size by Application
6.3.1 North America Proliferative Diabetic Retinopathy Market Size by Application (2016-2021)
6.3.2 North America Proliferative Diabetic Retinopathy Market Size by Application (2022-2027)
6.3.3 North America Proliferative Diabetic Retinopathy Market Size by Application (2016-2027)
6.4 North America Proliferative Diabetic Retinopathy Market Size by Country
6.4.1 North America Proliferative Diabetic Retinopathy Market Size by Country (2016-2021)
6.4.2 North America Proliferative Diabetic Retinopathy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Proliferative Diabetic Retinopathy Market Size (2016-2027)
7.2 Europe Proliferative Diabetic Retinopathy Market Size by Type
7.2.1 Europe Proliferative Diabetic Retinopathy Market Size by Type (2016-2021)
7.2.2 Europe Proliferative Diabetic Retinopathy Market Size by Type (2022-2027)
7.2.3 Europe Proliferative Diabetic Retinopathy Market Size by Type (2016-2027)
7.3 Europe Proliferative Diabetic Retinopathy Market Size by Application
7.3.1 Europe Proliferative Diabetic Retinopathy Market Size by Application (2016-2021)
7.3.2 Europe Proliferative Diabetic Retinopathy Market Size by Application (2022-2027)
7.3.3 Europe Proliferative Diabetic Retinopathy Market Size by Application (2016-2027)
7.4 Europe Proliferative Diabetic Retinopathy Market Size by Country
7.4.1 Europe Proliferative Diabetic Retinopathy Market Size by Country (2016-2021)
7.4.2 Europe Proliferative Diabetic Retinopathy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Proliferative Diabetic Retinopathy Market Size (2016-2027)
8.2 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Type
8.2.1 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Type (2016-2027)
8.3 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Application
8.3.1 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Application (2016-2027)
8.4 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Region
8.4.1 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Proliferative Diabetic Retinopathy Market Size (2016-2027)
9.2 Latin America Proliferative Diabetic Retinopathy Market Size by Type
9.2.1 Latin America Proliferative Diabetic Retinopathy Market Size by Type (2016-2021)
9.2.2 Latin America Proliferative Diabetic Retinopathy Market Size by Type (2022-2027)
9.2.3 Latin America Proliferative Diabetic Retinopathy Market Size by Type (2016-2027)
9.3 Latin America Proliferative Diabetic Retinopathy Market Size by Application
9.3.1 Latin America Proliferative Diabetic Retinopathy Market Size by Application (2016-2021)
9.3.2 Latin America Proliferative Diabetic Retinopathy Market Size by Application (2022-2027)
9.3.3 Latin America Proliferative Diabetic Retinopathy Market Size by Application (2016-2027)
9.4 Latin America Proliferative Diabetic Retinopathy Market Size by Country
9.4.1 Latin America Proliferative Diabetic Retinopathy Market Size by Country (2016-2021)
9.4.2 Latin America Proliferative Diabetic Retinopathy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Proliferative Diabetic Retinopathy Market Size (2016-2027)
10.2 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Type
10.2.1 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Type (2016-2027)
10.3 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Application
10.3.1 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Application (2016-2027)
10.4 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Country
10.4.1 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Intas Pharmaceuticals
11.1.1 Intas Pharmaceuticals Company Details
11.1.2 Intas Pharmaceuticals Business Overview
11.1.3 Intas Pharmaceuticals Proliferative Diabetic Retinopathy Introduction
11.1.4 Intas Pharmaceuticals Revenue in Proliferative Diabetic Retinopathy Business (2016-2021)
11.1.5 Intas Pharmaceuticals Recent Development
11.2 Santen Pharmaceutical
11.2.1 Santen Pharmaceutical Company Details
11.2.2 Santen Pharmaceutical Business Overview
11.2.3 Santen Pharmaceutical Proliferative Diabetic Retinopathy Introduction
11.2.4 Santen Pharmaceutical Revenue in Proliferative Diabetic Retinopathy Business (2016-2021)
11.2.5 Santen Pharmaceutical Recent Development
11.3 Bausch Health
11.3.1 Bausch Health Company Details
11.3.2 Bausch Health Business Overview
11.3.3 Bausch Health Proliferative Diabetic Retinopathy Introduction
11.3.4 Bausch Health Revenue in Proliferative Diabetic Retinopathy Business (2016-2021)
11.3.5 Bausch Health Recent Development
11.4 Allergan Plc
11.4.1 Allergan Plc Company Details
11.4.2 Allergan Plc Business Overview
11.4.3 Allergan Plc Proliferative Diabetic Retinopathy Introduction
11.4.4 Allergan Plc Revenue in Proliferative Diabetic Retinopathy Business (2016-2021)
11.4.5 Allergan Plc Recent Development
11.5 Regeneron Pharmaceuticals
11.5.1 Regeneron Pharmaceuticals Company Details
11.5.2 Regeneron Pharmaceuticals Business Overview
11.5.3 Regeneron Pharmaceuticals Proliferative Diabetic Retinopathy Introduction
11.5.4 Regeneron Pharmaceuticals Revenue in Proliferative Diabetic Retinopathy Business (2016-2021)
11.5.5 Regeneron Pharmaceuticals Recent Development
11.6 Merck KGaA
11.6.1 Merck KGaA Company Details
11.6.2 Merck KGaA Business Overview
11.6.3 Merck KGaA Proliferative Diabetic Retinopathy Introduction
11.6.4 Merck KGaA Revenue in Proliferative Diabetic Retinopathy Business (2016-2021)
11.6.5 Merck KGaA Recent Development
11.7 Cipla
11.7.1 Cipla Company Details
11.7.2 Cipla Business Overview
11.7.3 Cipla Proliferative Diabetic Retinopathy Introduction
11.7.4 Cipla Revenue in Proliferative Diabetic Retinopathy Business (2016-2021)
11.7.5 Cipla Recent Development
11.8 Genentech, Inc. (Roche Holdings)
11.8.1 Genentech, Inc. (Roche Holdings) Company Details
11.8.2 Genentech, Inc. (Roche Holdings) Business Overview
11.8.3 Genentech, Inc. (Roche Holdings) Proliferative Diabetic Retinopathy Introduction
11.8.4 Genentech, Inc. (Roche Holdings) Revenue in Proliferative Diabetic Retinopathy Business (2016-2021)
11.8.5 Genentech, Inc. (Roche Holdings) Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Proliferative Diabetic Retinopathy Introduction
11.9.4 Novartis Revenue in Proliferative Diabetic Retinopathy Business (2016-2021)
11.9.5 Novartis Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Proliferative Diabetic Retinopathy Introduction
11.10.4 Pfizer Revenue in Proliferative Diabetic Retinopathy Business (2016-2021)
11.10.5 Pfizer Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Proliferative Diabetic Retinopathy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anti-VEGF Agents
Table 3. Key Players of Corticosteroids
Table 4. Global Proliferative Diabetic Retinopathy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Proliferative Diabetic Retinopathy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Proliferative Diabetic Retinopathy Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Proliferative Diabetic Retinopathy Market Share by Regions (2016-2021)
Table 8. Global Proliferative Diabetic Retinopathy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Proliferative Diabetic Retinopathy Market Share by Regions (2022-2027)
Table 10. Proliferative Diabetic Retinopathy Market Trends
Table 11. Proliferative Diabetic Retinopathy Market Drivers
Table 12. Proliferative Diabetic Retinopathy Market Challenges
Table 13. Proliferative Diabetic Retinopathy Market Restraints
Table 14. Global Proliferative Diabetic Retinopathy Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Proliferative Diabetic Retinopathy Market Share by Players (2016-2021)
Table 16. Global Top Proliferative Diabetic Retinopathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Proliferative Diabetic Retinopathy as of 2020)
Table 17. Ranking of Global Top Proliferative Diabetic Retinopathy Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Proliferative Diabetic Retinopathy Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Proliferative Diabetic Retinopathy Product Solution and Service
Table 21. Date of Enter into Proliferative Diabetic Retinopathy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Proliferative Diabetic Retinopathy Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Proliferative Diabetic Retinopathy Revenue Market Share by Type (2016-2021)
Table 25. Global Proliferative Diabetic Retinopathy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Proliferative Diabetic Retinopathy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Proliferative Diabetic Retinopathy Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Proliferative Diabetic Retinopathy Revenue Market Share by Application (2016-2021)
Table 29. Global Proliferative Diabetic Retinopathy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Proliferative Diabetic Retinopathy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Proliferative Diabetic Retinopathy Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Proliferative Diabetic Retinopathy Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Proliferative Diabetic Retinopathy Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Proliferative Diabetic Retinopathy Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Proliferative Diabetic Retinopathy Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Proliferative Diabetic Retinopathy Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Proliferative Diabetic Retinopathy Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Proliferative Diabetic Retinopathy Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Proliferative Diabetic Retinopathy Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Proliferative Diabetic Retinopathy Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Proliferative Diabetic Retinopathy Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Proliferative Diabetic Retinopathy Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Proliferative Diabetic Retinopathy Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Proliferative Diabetic Retinopathy Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Proliferative Diabetic Retinopathy Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Proliferative Diabetic Retinopathy Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Proliferative Diabetic Retinopathy Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Proliferative Diabetic Retinopathy Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Country (2022-2027) & (US$ Million)
Table 61. Intas Pharmaceuticals Company Details
Table 62. Intas Pharmaceuticals Business Overview
Table 63. Intas Pharmaceuticals Proliferative Diabetic Retinopathy Product
Table 64. Intas Pharmaceuticals Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) & (US$ Million)
Table 65. Intas Pharmaceuticals Recent Development
Table 66. Santen Pharmaceutical Company Details
Table 67. Santen Pharmaceutical Business Overview
Table 68. Santen Pharmaceutical Proliferative Diabetic Retinopathy Product
Table 69. Santen Pharmaceutical Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) & (US$ Million)
Table 70. Santen Pharmaceutical Recent Development
Table 71. Bausch Health Company Details
Table 72. Bausch Health Business Overview
Table 73. Bausch Health Proliferative Diabetic Retinopathy Product
Table 74. Bausch Health Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) & (US$ Million)
Table 75. Bausch Health Recent Development
Table 76. Allergan Plc Company Details
Table 77. Allergan Plc Business Overview
Table 78. Allergan Plc Proliferative Diabetic Retinopathy Product
Table 79. Allergan Plc Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) & (US$ Million)
Table 80. Allergan Plc Recent Development
Table 81. Regeneron Pharmaceuticals Company Details
Table 82. Regeneron Pharmaceuticals Business Overview
Table 83. Regeneron Pharmaceuticals Proliferative Diabetic Retinopathy Product
Table 84. Regeneron Pharmaceuticals Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) & (US$ Million)
Table 85. Regeneron Pharmaceuticals Recent Development
Table 86. Merck KGaA Company Details
Table 87. Merck KGaA Business Overview
Table 88. Merck KGaA Proliferative Diabetic Retinopathy Product
Table 89. Merck KGaA Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) & (US$ Million)
Table 90. Merck KGaA Recent Development
Table 91. Cipla Company Details
Table 92. Cipla Business Overview
Table 93. Cipla Proliferative Diabetic Retinopathy Product
Table 94. Cipla Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) & (US$ Million)
Table 95. Cipla Recent Development
Table 96. Genentech, Inc. (Roche Holdings) Company Details
Table 97. Genentech, Inc. (Roche Holdings) Business Overview
Table 98. Genentech, Inc. (Roche Holdings) Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) & (US$ Million)
Table 99. Genentech, Inc. (Roche Holdings) Recent Development
Table 100. Novartis Company Details
Table 101. Novartis Business Overview
Table 102. Novartis Proliferative Diabetic Retinopathy Product
Table 103. Novartis Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) & (US$ Million)
Table 104. Novartis Recent Development
Table 105. Pfizer Company Details
Table 106. Pfizer Business Overview
Table 107. Pfizer Proliferative Diabetic Retinopathy Product
Table 108. Pfizer Revenue in Proliferative Diabetic Retinopathy Business (2016-2021) & (US$ Million)
Table 109. Pfizer Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Proliferative Diabetic Retinopathy Market Share by Type: 2020 VS 2027
Figure 2. Anti-VEGF Agents Features
Figure 3. Corticosteroids Features
Figure 4. Global Proliferative Diabetic Retinopathy Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Proliferative Diabetic Retinopathy Report Years Considered
Figure 9. Global Proliferative Diabetic Retinopathy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Proliferative Diabetic Retinopathy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Proliferative Diabetic Retinopathy Market Share by Regions: 2020 VS 2027
Figure 12. Global Proliferative Diabetic Retinopathy Market Share by Regions (2022-2027)
Figure 13. Global Proliferative Diabetic Retinopathy Market Share by Players in 2020
Figure 14. Global Top Proliferative Diabetic Retinopathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Proliferative Diabetic Retinopathy as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Proliferative Diabetic Retinopathy Revenue in 2020
Figure 16. Global Proliferative Diabetic Retinopathy Revenue Market Share by Type (2016-2021)
Figure 17. Global Proliferative Diabetic Retinopathy Revenue Market Share by Type (2022-2027)
Figure 18. North America Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Proliferative Diabetic Retinopathy Market Share by Type (2016-2027)
Figure 20. North America Proliferative Diabetic Retinopathy Market Share by Application (2016-2027)
Figure 21. North America Proliferative Diabetic Retinopathy Market Share by Country (2016-2027)
Figure 22. United States Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Proliferative Diabetic Retinopathy Market Share by Type (2016-2027)
Figure 26. Europe Proliferative Diabetic Retinopathy Market Share by Application (2016-2027)
Figure 27. Europe Proliferative Diabetic Retinopathy Market Share by Country (2016-2027)
Figure 28. Germany Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Proliferative Diabetic Retinopathy Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Proliferative Diabetic Retinopathy Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Proliferative Diabetic Retinopathy Market Share by Region (2016-2027)
Figure 38. China Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Proliferative Diabetic Retinopathy Market Share by Type (2016-2027)
Figure 46. Latin America Proliferative Diabetic Retinopathy Market Share by Application (2016-2027)
Figure 47. Latin America Proliferative Diabetic Retinopathy Market Share by Country (2016-2027)
Figure 48. Mexico Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Proliferative Diabetic Retinopathy Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Proliferative Diabetic Retinopathy Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Proliferative Diabetic Retinopathy Market Share by Country (2016-2027)
Figure 54. Turkey Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Proliferative Diabetic Retinopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Intas Pharmaceuticals Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2016-2021)
Figure 58. Santen Pharmaceutical Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2016-2021)
Figure 59. Bausch Health Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2016-2021)
Figure 60. Allergan Plc Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2016-2021)
Figure 61. Regeneron Pharmaceuticals Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2016-2021)
Figure 62. Merck KGaA Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2016-2021)
Figure 63. Cipla Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2016-2021)
Figure 64. Genentech, Inc. (Roche Holdings) Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の糖尿病網膜症治療市場規模・現状・予測（2021年-2027年） Diabetic retinopathy (die-uh-BET-ik ret-ih-NOP-uh-thee) is a diabetes complication that affects eyes. It's caused by damage to the blood vessels of the light-sensitive tissue at the back of the eye (retina). Market Analysis and Insights: Global Diabetic Retinopathy Treatment Market The global Diabet…- 世界の糖尿病網膜症市場規模・現状・予測（2021年-2027年） Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabe…
- 世界の糖尿病網膜症市場規模・現状・予測（2021年-2027年） Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabe…
- 世界の糖尿病網膜症治療薬市場規模・現状・予測（2021年-2027年） Diabetic retinopathy is an ophthalmic disorder, in which blindness occurrs due to complications in diabetes. The North American region is the most lucrative market, owing to large number of elderly population in the U.S. However, European and Asia-Pacific regions are considered as the most promising…
- 世界の黄斑変性症（AMD）・糖尿病性網膜症（DR）治療薬市場規模・現状・予測（2021年-2027年） Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above. Diabetic retinopathy is an ophthalmic disorder, in which b…